From Elsevier Business Intelligence
Including company and deal data plus articles from publications like IN VIVO, Start-Up, The RPM Report, and Medtech Insight.

UCB Pharma SA

www.ucbpharma.com

Most Recent Related Deals

Wilex takes on UCB's cancer business, 1/2009
Millennium signs deal with UCB for two antibodies, 1/2005
UCB Farmchim/Dynavax allergy deal terminated, 2/2004
UCB markets Watson's incontinence drug; terminated, 9/2003
Elan, UCB Pharma co-promote Frova in the US, 3/2002
BioFocus and UCB in GPCR drug discovery alliance, 2/2002
Euroscreen, UCB develop screening technologies , 11/1999
Gene Logic looks for asthma, allergy genes for UCB, 9/1999
Genfit, UCB Pharma develop respiratory, allergy drugs, 9/1999
CytoMed, UCB Pharma pen anti-inflammatory research agreement, 3/1998

Most Recent Related Articles

Click an article to see a free preview (15 of 23).

Running Late: FDA Review Timelines Lengthen For New Product Applications, The RPM Report 9/2008
Running Late: FDA Review Timelines Lengthen For New Product Applications, Medtech Insight 9/2008
Best of the Blog: IN VIVO, June 2008, IN VIVO 6/2008
Woodcock to the Rescue: Is CDER Approving More Products?, The RPM Report 5/2008
Woodcock to the Rescue: Is CDER Approving More Products?, Medtech Insight 5/2008
Death to the Primary Care Blockbuster? What 2007 Says About the Future of the Drug Industry, The RPM Report 3/2008
In Endo, Vernalis Finds a Believer in Frova, Start-Up 9/2004
In Endo, Vernalis Finds a Believer in Frova, IN VIVO 9/2004
Are Late-Stage Deals Beginning to Lose Their Luster?, Start-Up 6/2004
Are Late-Stage Deals Beginning to Lose Their Luster?, IN VIVO 6/2004
Bioteching UCB-and Maybe Mid-Sized Pharma, Too, Start-Up 6/2004
Bioteching UCB-and Maybe Mid-Sized Pharma, Too, IN VIVO 6/2004
Celltech-UCB: UK's Loss Could be Mid-Sized Pharma's Gain, RPM Report 6/2004
Celltech-UCB: UK's Loss Could be Mid-Sized Pharma's Gain, IN VIVO Europe Rx 6/2004
Kos: Right-Sizing Expectations, Start-Up 5/2004

See all 23 articles about this company

Copyright © 2009 Elsevier Inc. All rights reserved. Elsevier Business Intelligence, www.ElsevierBI.com.
Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com.